Showing 1081-1090 of 2876 results for "".
- Modern Aesthetics® Announces New Tweet Chat Series -- #RealDealAestheticshttps://modernaesthetics.com/news/modern-aesthetics-announces-new-tweet-chat-series-realdealaesthetics/2472073/Modern Aesthetics® magazine is launching a new Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD. The first Tweet chat focuses on filler selection in a r
- ARTAS Training Available: Restoration Robotics Launches Continuing Education Serieshttps://modernaesthetics.com/news/artas-training-available-restoration-robotics-launches-continuing-education-series/2472080/Restoration Robotics, Inc. is launching a continuing education Master Class Series for its ARTAS® Robotic Hair Restoration System to train physicians on best practices and the most up-to-date techniques for the technology. The Master Class Series will enable users to provide exceptional
- Revance Vet Tapped as New Evolus CFOhttps://modernaesthetics.com/news/revance-vet-tapped-as-new-evolus-cfo/2472086/Lauren Silvernail is the new Chief Financial Officer and Executive Vice President, Corporate Development at Evolus, Inc. Silvernail joins Evolus from Revance Therapeutics where she most recently served as Chief Financial Officer and Chief Business Officer. Prior to her time at Revance The
- Restylane Lyft Now FDA-Approved for Handshttps://modernaesthetics.com/news/restylane-lyft-now-fda-approved-for-hands/2472088/The US Food and Drug Administration has approved Restylane Lyft for use on the dorsal hands of people older then 21, making it the first hyaluronic acid (HA) injectable gel approved for this use. Radiesse (Calcium Hydroxylapatite) is also approved for the correction of lost
- FDA Says No to Evolus' Botox Rivalhttps://modernaesthetics.com/news/fda-says-no-to-evolus-botox-rival/2472089/The U.S Food and Drug Administration did not approve DWP-450, Evolus Inc's rival product to Allergan Plc's Botox, due to chemistry and manufacturing issues. As a result, the company pushed its estimate for the launch of the drug to the spring of next year. Read more
- Sciton Names New Leadership Teamhttps://modernaesthetics.com/news/sciton-names-new-leadership-team/2472093/Sciton has an all new leadership team. The new Sciton leaders are: Aaron Burton, Chief Operating Officer Todd Sternbach, Vice President of Strategic Sales Initiatives David Percival, Vice President / General Manager of Sciton Intern
- Carrie Strom is Allergan's New Senior Vice President, U.S. Medical Aestheticshttps://modernaesthetics.com/news/carrie-strom-is-allergans-new-senior-vice-president-us-medical-aesthetics/2472094/Carrie Strom is Allergan’s new Senior Vice President, U.S. Medical Aesthetics, a portfolio of brands including BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® Collection of Fillers, Natrelle® col
- Cutera Marks 20 Years of Innovationhttps://modernaesthetics.com/news/cuter-marks-20-years-of-innovation/2472102/Cutera, Inc. is celebrating 20 years of best-in-class product innovation with continued commitment to the industry and its providers, marking the milestone at the Annual Meeting of the American Society for Laser Medicine and Surgery in Dallas. In conjunction with the 20th&nbs
- New Line of Laser Systems Now Available from Sensus Healthcarehttps://modernaesthetics.com/news/new-line-of-lasers-systems-now-available-from-sensus-healthcare/2472120/Sensus Healthcare, Inc. has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective lasers for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment. Prior to this launch, the medical device company specialized
- New From Cutera: Juliet and Secret RFhttps://modernaesthetics.com/news/new-from-cutera-juliet-and-secret-rf/2472149/Cutera has introduced two new devices to its laser and energy-based device offerings: Juliet™ and Secret RF